PDB Short entry for 4GFG HEADER TRANSFERASE/TRANSFERASE INHIBITOR 03-AUG-12 4GFG TITLE CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITH R9021 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE SYK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: SPLEEN TYROSINE KINASE, P72-SYK; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SYK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9 KEYWDS SYK, SPLEEN TYPROSINE KINASE, PYRIMIDINE-5-CARBOXAMIDE, ATP-BINDING, KEYWDS 2 HOST-VIRUS INTERACTION, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SH2 KEYWDS 3 DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.LUKACS,M.SLADE REVDAT 3 13-SEP-23 4GFG 1 REMARK SEQADV REVDAT 2 15-NOV-17 4GFG 1 REMARK REVDAT 1 14-AUG-13 4GFG 0 JRNL AUTH J.HSU,Y.KIM,D.-Q.HU,D.XU,J.ZHANG,A.PASHINE,J.MENKE, JRNL AUTH 2 T.WHITTARD,N.ROMERO,T.TRUITT,C.LUKACS,M.ZHOU,M.LUCAS, JRNL AUTH 3 M.SLADE,J.DEMARTINO,S.-L.TAN,C.LIAO JRNL TITL A SPECIFIC SYK INHIBITOR BLOCKS B CELL RECEPTOR, FC JRNL TITL 2 RECEPTOR, AND TOLL-LIKE RECEPTOR 9 PATHWAYS FOR THE JRNL TITL 3 TREATMENT OF INFLAMMATORY DISEASES. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.47 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1130698.810 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 13570 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.221 REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 673 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2400 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2380 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 673 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0100 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 13570 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.35 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.50 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2106 REMARK 3 BIN R VALUE (WORKING SET) : 0.3010 REMARK 3 BIN FREE R VALUE : 0.3650 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 110 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.035 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2252 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 101 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.55000 REMARK 3 B22 (A**2) : -8.69000 REMARK 3 B33 (A**2) : 10.24000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.26 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.34 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 0.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.630 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.500 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.510 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.120 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.080 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.43 REMARK 3 BSOL : 72.25 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARA REMARK 3 PARAMETER FILE 2 : LIG.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : LIG.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4GFG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1000074115. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-MAY-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9999 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13618 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.350 REMARK 200 RESOLUTION RANGE LOW (A) : 62.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.48 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 6.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.40800 REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CCP4 REMARK 200 STARTING MODEL: PDB ENTRY 3FQE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% PEG 3350, 0.1M SODIUM MALONATE, PH REMARK 280 4.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 278K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.03050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.46500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.82350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.46500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.03050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.82350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 353 REMARK 465 ALA A 354 REMARK 465 LEU A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 ILE A 358 REMARK 465 ARG A 359 REMARK 465 PRO A 360 REMARK 465 LYS A 361 REMARK 465 GLU A 362 REMARK 465 HIS A 640 REMARK 465 HIS A 641 REMARK 465 HIS A 642 REMARK 465 HIS A 643 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 374 -18.78 -49.87 REMARK 500 ASN A 381 20.17 -64.39 REMARK 500 GLN A 391 94.15 -65.07 REMARK 500 MET A 392 -164.08 -68.15 REMARK 500 LYS A 394 -41.82 -130.78 REMARK 500 LYS A 405 107.72 -54.70 REMARK 500 ASN A 406 102.50 -59.57 REMARK 500 ALA A 408 -119.12 54.15 REMARK 500 PRO A 411 32.90 -78.02 REMARK 500 ASN A 429 141.91 -171.16 REMARK 500 ALA A 441 -137.70 -143.81 REMARK 500 ASP A 494 42.97 -145.64 REMARK 500 ASP A 512 68.78 61.44 REMARK 500 THR A 530 -164.27 -128.88 REMARK 500 HIS A 531 160.19 165.25 REMARK 500 PRO A 535 68.92 -65.63 REMARK 500 TRP A 609 37.23 -92.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA A 408 ASN A 409 83.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0XF A 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3FQE RELATED DB: PDB DBREF 4GFG A 356 635 UNP P43405 KSYK_HUMAN 356 635 SEQADV 4GFG MET A 353 UNP P43405 EXPRESSION TAG SEQADV 4GFG ALA A 354 UNP P43405 EXPRESSION TAG SEQADV 4GFG LEU A 355 UNP P43405 EXPRESSION TAG SEQADV 4GFG GLU A 636 UNP P43405 EXPRESSION TAG SEQADV 4GFG GLY A 637 UNP P43405 EXPRESSION TAG SEQADV 4GFG HIS A 638 UNP P43405 EXPRESSION TAG SEQADV 4GFG HIS A 639 UNP P43405 EXPRESSION TAG SEQADV 4GFG HIS A 640 UNP P43405 EXPRESSION TAG SEQADV 4GFG HIS A 641 UNP P43405 EXPRESSION TAG SEQADV 4GFG HIS A 642 UNP P43405 EXPRESSION TAG SEQADV 4GFG HIS A 643 UNP P43405 EXPRESSION TAG SEQRES 1 A 291 MET ALA LEU GLU GLU ILE ARG PRO LYS GLU VAL TYR LEU SEQRES 2 A 291 ASP ARG LYS LEU LEU THR LEU GLU ASP LYS GLU LEU GLY SEQRES 3 A 291 SER GLY ASN PHE GLY THR VAL LYS LYS GLY TYR TYR GLN SEQRES 4 A 291 MET LYS LYS VAL VAL LYS THR VAL ALA VAL LYS ILE LEU SEQRES 5 A 291 LYS ASN GLU ALA ASN ASP PRO ALA LEU LYS ASP GLU LEU SEQRES 6 A 291 LEU ALA GLU ALA ASN VAL MET GLN GLN LEU ASP ASN PRO SEQRES 7 A 291 TYR ILE VAL ARG MET ILE GLY ILE CYS GLU ALA GLU SER SEQRES 8 A 291 TRP MET LEU VAL MET GLU MET ALA GLU LEU GLY PRO LEU SEQRES 9 A 291 ASN LYS TYR LEU GLN GLN ASN ARG HIS VAL LYS ASP LYS SEQRES 10 A 291 ASN ILE ILE GLU LEU VAL HIS GLN VAL SER MET GLY MET SEQRES 11 A 291 LYS TYR LEU GLU GLU SER ASN PHE VAL HIS ARG ASP LEU SEQRES 12 A 291 ALA ALA ARG ASN VAL LEU LEU VAL THR GLN HIS TYR ALA SEQRES 13 A 291 LYS ILE SER ASP PHE GLY LEU SER LYS ALA LEU ARG ALA SEQRES 14 A 291 ASP GLU ASN TYR TYR LYS ALA GLN THR HIS GLY LYS TRP SEQRES 15 A 291 PRO VAL LYS TRP TYR ALA PRO GLU CYS ILE ASN TYR TYR SEQRES 16 A 291 LYS PHE SER SER LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 17 A 291 LEU MET TRP GLU ALA PHE SER TYR GLY GLN LYS PRO TYR SEQRES 18 A 291 ARG GLY MET LYS GLY SER GLU VAL THR ALA MET LEU GLU SEQRES 19 A 291 LYS GLY GLU ARG MET GLY CYS PRO ALA GLY CYS PRO ARG SEQRES 20 A 291 GLU MET TYR ASP LEU MET ASN LEU CYS TRP THR TYR ASP SEQRES 21 A 291 VAL GLU ASN ARG PRO GLY PHE ALA ALA VAL GLU LEU ARG SEQRES 22 A 291 LEU ARG ASN TYR TYR TYR ASP VAL VAL ASN GLU GLY HIS SEQRES 23 A 291 HIS HIS HIS HIS HIS HET 0XF A 701 26 HETNAM 0XF 6-{[(1R,2S)-2-AMINOCYCLOHEXYL]AMINO}-4-[(5,6- HETNAM 2 0XF DIMETHYLPYRIDIN-2-YL)AMINO]PYRIDAZINE-3-CARBOXAMIDE FORMUL 2 0XF C18 H25 N7 O FORMUL 3 HOH *101(H2 O) HELIX 1 1 ASP A 366 LYS A 368 5 3 HELIX 2 2 PRO A 411 GLN A 426 1 16 HELIX 3 3 LEU A 456 GLN A 462 1 7 HELIX 4 4 LYS A 467 SER A 488 1 22 HELIX 5 5 ALA A 496 ARG A 498 5 3 HELIX 6 6 PRO A 535 TYR A 539 5 5 HELIX 7 7 ALA A 540 TYR A 547 1 8 HELIX 8 8 SER A 550 SER A 567 1 18 HELIX 9 9 LYS A 577 LYS A 587 1 11 HELIX 10 10 PRO A 598 TRP A 609 1 12 HELIX 11 11 ASP A 612 ARG A 616 5 5 HELIX 12 12 GLY A 618 HIS A 638 1 21 SHEET 1 A 5 LEU A 370 GLY A 380 0 SHEET 2 A 5 GLY A 383 GLN A 391 -1 O GLY A 383 N GLY A 380 SHEET 3 A 5 VAL A 396 LEU A 404 -1 O LYS A 397 N TYR A 390 SHEET 4 A 5 TRP A 444 GLU A 449 -1 O MET A 448 N ALA A 400 SHEET 5 A 5 MET A 435 GLU A 440 -1 N ILE A 436 O VAL A 447 SHEET 1 B 3 GLY A 454 PRO A 455 0 SHEET 2 B 3 VAL A 500 THR A 504 -1 O LEU A 502 N GLY A 454 SHEET 3 B 3 TYR A 507 ILE A 510 -1 O TYR A 507 N VAL A 503 SHEET 1 C 2 PHE A 490 VAL A 491 0 SHEET 2 C 2 LYS A 517 ALA A 518 -1 O LYS A 517 N VAL A 491 SHEET 1 D 2 TYR A 526 LYS A 527 0 SHEET 2 D 2 LYS A 548 PHE A 549 -1 O PHE A 549 N TYR A 526 SITE 1 AC1 11 LEU A 377 SER A 379 ALA A 400 MET A 448 SITE 2 AC1 11 GLU A 449 ALA A 451 GLY A 454 ARG A 498 SITE 3 AC1 11 ASN A 499 LEU A 501 ASP A 512 CRYST1 40.061 85.647 90.930 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024962 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011676 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010997 0.00000